Raju Prasad
Stock Analyst at William Blair
(0.02)
# 4,346
Out of 4,711 analysts
13
Total ratings
16.67%
Success rate
-47.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raju Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics | Downgrades: Market Perform | n/a | $9.45 | - | 1 | Nov 26, 2024 | |
| DTIL Precision BioSciences | Downgrades: Market Perform | n/a | $4.72 | - | 1 | Jun 9, 2022 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | n/a | $12.18 | - | 1 | Feb 18, 2022 | |
| LOGC ContextLogic | Downgrades: Market Perform | n/a | $6.73 | - | 1 | Feb 3, 2022 | |
| ASMB Assembly Biosciences | Downgrades: Market Perform | n/a | $15.21 | - | 1 | Sep 2, 2021 | |
| VERV Verve Therapeutics | Initiates: Outperform | $92 | $5.74 | +1,502.79% | 1 | Jul 12, 2021 | |
| TSHA Taysha Gene Therapies | Initiates: Outperform | $46 | $1.85 | +2,386.49% | 1 | Feb 24, 2021 | |
| GBIO Generation Bio Co. | Initiates: Outperform | $45 | $1.19 | +3,681.51% | 1 | Feb 24, 2021 | |
| CRSP CRISPR Therapeutics AG | Initiates: Market Perform | n/a | $40.72 | - | 1 | Mar 14, 2019 | |
| BOLD Boundless Bio | Downgrades: Market Perform | n/a | $2.59 | - | 2 | Nov 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $46.24 | - | 2 | Jun 18, 2018 |
Poseida Therapeutics
Nov 26, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $9.45
Upside: -
Precision BioSciences
Jun 9, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $4.72
Upside: -
Intellia Therapeutics
Feb 18, 2022
Initiates: Outperform
Price Target: n/a
Current: $12.18
Upside: -
ContextLogic
Feb 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $6.73
Upside: -
Assembly Biosciences
Sep 2, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $15.21
Upside: -
Verve Therapeutics
Jul 12, 2021
Initiates: Outperform
Price Target: $92
Current: $5.74
Upside: +1,502.79%
Taysha Gene Therapies
Feb 24, 2021
Initiates: Outperform
Price Target: $46
Current: $1.85
Upside: +2,386.49%
Generation Bio Co.
Feb 24, 2021
Initiates: Outperform
Price Target: $45
Current: $1.19
Upside: +3,681.51%
CRISPR Therapeutics AG
Mar 14, 2019
Initiates: Market Perform
Price Target: n/a
Current: $40.72
Upside: -
Boundless Bio
Nov 7, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $2.59
Upside: -
Jun 18, 2018
Upgrades: Outperform
Price Target: n/a
Current: $46.24
Upside: -